Daily Glucagon-like Peptide-1 Receptor Agonists in Type 1 Diabetes: What we’ve Learned and What Comes Next

Endocrinology & Metabolism Clinics of North America · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles